Floatz logo

714 assets in Colorectal Cancer

Therapeutic assets addressing Colorectal Cancer, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Oxaliplatin
Colorectal Cancer
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.P4BB (70)
Fluorouracilum
Colorectal Cancer
UNICANCERP4BB (68)
Levofolinic Acid
Colorectal Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.P3BB (68)
Panitumumab
Colorectal Cancer
MSPU des 3 ProvincesP3BB (68)
Adebrelimab
Colorectal Cancer
Huazhong University of Science and TechnologyP4BB (67)
Arfolitixorin
Colorectal Cancer
Isofol Medical ABP3BB (67)
Capecitabine
Colorectal Cancer
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.P4BB (67)
Cetuximab
Colorectal Cancer
Fudan UniversityP4BB (67)
Fruquintinib
Colorectal Cancer
Jiangsu Cancer Institute & HospitalP4BB (67)
Irinotecan
Colorectal Cancer
UNICANCERP4BB (67)
Moviprep
Colorectal Cancer
Radboud University Medical CenterP4BB (67)
Regorafenib
Colorectal Cancer
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.P4BB (67)
Tipiracil
Colorectal Cancer
M.D. Anderson Cancer CenterP3BB (67)
Trifluridine
Colorectal Cancer
M.D. Anderson Cancer CenterP3BB (67)
Cyclophosphamide
Colorectal Cancer
University of PennsylvaniaP2/3BB (66)
Immunoglobulin G1, Anti-(Human Epidermal Growth Factor Receptor Her2) (Human-Mus Musculus Monoclonal Shr-1805 ?1-Chain), Complex With Human-Mus Musculus Monoclonal Shr-1805 ?-Chain, Dimer, Thioether With N-[6-(3-Mercapto-2,5-Dioxo-1-Pyrrolidinyl)-1-Oxohexyl]Glycylglycyl-L-Phenylalanyl-N-[[(1R)-1-Cyclopropyl-2-[[(1S,9S)-9-Ethyl-5-Fluoro-2,3,9,10,13,15-Hexahydro-9-Hydroxy-4-Methyl-10,13-Dioxo-1H,12H-Benzo[De]Pyrano[3?,4?:6,7]Indolizino[1,2-B]Quinolin-1-Yl]Amino]-2-Oxoethoxy]Methyl]Glycinamide
Colorectal Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.P3BB (66)
Magnesium Metallicum
Colorectal Cancer
Kaohsiung Medical University Chung-Ho Memorial HospitalP4BB (66)
Dexasone
Colorectal Cancer
Institute of Oncology LjubljanaP4BB (65)
Rivaroxaban
Colorectal Cancer
Hospital do Servidor Publico EstadualP4BB (65)
Sulfave
Colorectal Cancer
Morehouse School of MedicineP4BB (65)
Sutab
Colorectal Cancer
Morehouse School of MedicineP4BB (65)
Tas-102
Colorectal Cancer
STCube, Inc.P3BB (65)
Tislelizumab
Colorectal Cancer
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus NordwestP3BB (65)
Celecoxib
Colorectal Cancer
Fudan UniversityP4BB (64)
Encorafenib
Colorectal Cancer
M.D. Anderson Cancer CenterP2BB (64)
Ferric Maltol
Colorectal Cancer
The Royal Wolverhampton Hospitals NHS TrustP3BB (64)
Immunoglobulin G1, Anti-(Human Epidermal Growth Factor Receptor) (Human-Mus Musculus Monoclonal Jmt101 ?1-Chain), Disulfide With Human-Mus Musculus Monoclonal Jmt101 ?-Chain, Dimer
Colorectal Cancer
Shanghai JMT-Bio Inc.P3BB (64)
Ivonescimab
Colorectal Cancer
UNICANCERP3BB (64)
Pentoxifylline
Colorectal Cancer
Tanta UniversityP2BB (64)
Pumitamig
Colorectal Cancer
Bristol-Myers SquibbP2/3BB (64)
Aspirin
Colorectal Cancer
The Nethersole School of NursingP3B (63)
Botensilimab
Colorectal Cancer
National Cancer Institute (NCI)P3B (63)
Lenvatinib
Colorectal Cancer
Seoul National University Bundang HospitalP3B (63)
Macrogols
Colorectal Cancer
Nanfang Hospital, Southern Medical UniversityP4B (63)
Nivolumab
Colorectal Cancer
Fred Hutchinson Cancer CenterP3B (63)
Pembrolizumab
Colorectal Cancer
National Cancer Center Hospital EastP4B (63)
Propofol
Colorectal Cancer
Fudan UniversityP4B (63)
Sevoflurane
Colorectal Cancer
Uppsala UniversityP4B (63)
Silymarin
Colorectal Cancer
Tanta UniversityP4B (63)
Vitamin D
Colorectal Cancer
Tanta UniversityP4B (63)
Catequentinib
Colorectal Cancer
Shanghai Changzheng HospitalP3B (62)
Cediranib
Colorectal Cancer
University Health Network, TorontoP4B (62)
Cik Cells
Colorectal Cancer
ShiCang YuP4B (62)
Lidocaine
Colorectal Cancer
Fudan UniversityP4B (62)
Raltitrexed
Colorectal Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP3B (62)
S-1
Colorectal Cancer
Tao ZhangP3B (62)
Tucidinostat
Colorectal Cancer
Shanghai Changzheng HospitalP3B (62)
Disitamab Vedotin
Colorectal Cancer
Anbogen Therapeutics, Inc.P4B (61)
Durvalumab
Colorectal Cancer
Gruppo Oncologico del Nord-OvestP2B (61)
Fludarabine
Colorectal Cancer
University of PennsylvaniaP2B (61)
Showing 1 to 50 of 714 assets
PreviousPage 1 of 15Next